Ayurvedic treatment of bronchial asthma

A CLINICAL STUDY ON THE MANAGEMENT OF TAMAKA SHWASA WITH SPECIAL REFERENCE TO BRONCHIAL ASTHMA WITH SHRUNGYADI SHAARKAR

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2017/12/010991

Enrollment

Registered

2017-12-27

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- tamaka shwasa

Interventions

Intervention1: SHRUGYAADI SHAARKAR: The drug Shrugyadi shaarkar consists Karkatashrungi, Sunthi, Pippali, Maricha, Kachura, Nagarmotha, Puskarmula, .All Seven drugs in equal quantity but Sharkara do

Eligibility

Inclusion criteria

Inclusion criteria: Patient manifesting the symptoms of Tamaka Shwasa

Exclusion criteria

Exclusion criteria: Severe cases of Asthma with complication like suspected infection larger airway lesion, heart disease etc. Cardiac complaints other chronic debilitating disease like HTN,T.B. AIDs, DM Allergic Bronchitis , COPD etc or other systemic and endocrine complaints associated with any degree of Asthma.

Design outcomes

Primary

Measure	Time frame
Scoring of important symptoms of Tamaka Shwaasa :Timepoint: 8 WEEKS	—

Secondary

Measure	Time frame
scale for quality of life(WHO-QoL BREF)in TAMAKA SHWASA, Deha Bala, Agni Bala, and Chetas BalaTimepoint: 8 WEEKS	—

Countries

India

Contacts

Public ContactMEENAKSGI VERMA

PARUL INSTITUTE OF AYURVEDA.PARUL UNIVERSITY

haresh.soni@paruluniversity.ac.in7878374848

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026